Groupama claims financial strength boost with sales

A view of the Eiffel Tower in Paris France

Groupama confirmed it will first sell a 6.5% stake in Silic for a 2.7% stake in CDC owned Icade and over time transfer its full holding again in a share exchange. Currently Groupama owns 44% of Silic with a reported value of €1.22bn.

The new holding company formed will have assets of over €9bn in business parks and offices in France.

In addition both parties have agreed that CDC will simultaneously purchase €300m shares issued by Groupama's wholly-owned subsidiary GAN Eurocourtage.


Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected].

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: